{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:41:09Z","timestamp":1792784469059,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Program of Postgraduate Joint Training Base of Chongqing"},{"name":"the Science and Technology Research Program of Chongqing Municipal Education Commission","award":["no. KJQN202000407"],"award-info":[{"award-number":["no. KJQN202000407"]}],"id":[{"id":"https:\/\/ror.org\/031nm5713","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s13346-023-01349-0","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T23:02:55Z","timestamp":1683759775000},"page":"2819-2833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Construction and evaluation of a phospholipid-based phase transition in situ gel system for brexpiprazole"],"prefix":"10.1007","volume":"13","author":[{"given":"Ran","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linbo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6941-2973","authenticated-orcid":false,"given":"Huali","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"1349_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jconrel.2022.07.006","volume":"349","author":"Y Mai","year":"2022","unstructured":"Mai Y, et al. Topical formulation based on disease-specific nanoparticles for single-dose cure of psoriasis. J Control Release. 2022;349:354\u201366.","journal-title":"J Control Release"},{"key":"1349_CR2","doi-asserted-by":"publisher","first-page":"9434820","DOI":"10.1155\/2022\/9434820","volume":"2022","author":"W Xu","year":"2022","unstructured":"Xu W, et al. Analysis of Factors Influencing Telemedicine-Based Psychiatric Extended Care and Care of Psychiatric Patients. J Healthc Eng. 2022;2022:9434820.","journal-title":"J Healthc Eng"},{"issue":"4","key":"1349_CR3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/ppc.12258","volume":"54","author":"T Aladeen","year":"2018","unstructured":"Aladeen T, et al. The use of brexpiprazole amongst individuals with insufficient outcomes with aripiprazole or bupropion: A case series. Perspect Psychiatr Care. 2018;54(4):507\u201313.","journal-title":"Perspect Psychiatr Care"},{"issue":"2","key":"1349_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.24869\/psyd.2022.308","volume":"34","author":"C Crapanzano","year":"2022","unstructured":"Crapanzano C, et al. Brexpiprazole 2 mg Starting Dose: A Case Series. Psychiatr Danub. 2022;34(2):308\u20139.","journal-title":"Psychiatr Danub"},{"issue":"1\u20132","key":"1349_CR5","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ijpharm.2012.05.006","volume":"434","author":"A Rawat","year":"2012","unstructured":"Rawat A, Bhardwaj U, Burgess DJ. Comparison of in vitro-in vivo release of Risperdal((R)) Consta((R)) microspheres. Int J Pharm. 2012;434(1\u20132):115\u201321.","journal-title":"Int J Pharm"},{"key":"1349_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121649","volume":"618","author":"SNR Shiadeh","year":"2022","unstructured":"Shiadeh SNR, et al. Lipid-liquid crystals for 2 months controlled risperidone release: In-vitro evaluation and pharmacokinetics in rabbits. Int J Pharm. 2022;618.","journal-title":"Int J Pharm"},{"issue":"5","key":"1349_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.18773\/austprescr.2017.064","volume":"40","author":"Brexpiprazole for schizophrenia","year":"2017","unstructured":"Brexpiprazole for schizophrenia. Aust Prescr. 2017;40(5):197\u20138.","journal-title":"Aust Prescr"},{"key":"1349_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2022.103121","volume":"72","author":"L Orsolini","year":"2022","unstructured":"Orsolini L, et al. A case report of clozapine-treatment-resistant schizophrenia successfully managed with brexpiprazole combination therapy. Asian J Psychiatr. 2022;72.","journal-title":"Asian J Psychiatr"},{"key":"1349_CR9","unstructured":"Brexpiprazole (Rexulti) for schizophrenia and depression. Med Lett Drugs Ther, 2015. 57(1475): p. 116-8.\u00a0https:\/\/secure.medicalletter.org\/TML-article-1475c."},{"issue":"2","key":"1349_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40265-019-1052-5","volume":"79","author":"JE Frampton","year":"2019","unstructured":"Frampton JE. Brexpiprazole: A Review in Schizophrenia. Drugs. 2019;79(2):189\u2013200.","journal-title":"Drugs"},{"issue":"12","key":"1349_CR11","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/mabi.200600129","volume":"6","author":"D Chitkara","year":"2006","unstructured":"Chitkara D, et al. Biodegradable injectable in situ depot-forming drug delivery systems. Macromol Biosci. 2006;6(12):977\u201390.","journal-title":"Macromol Biosci"},{"key":"1349_CR12","doi-asserted-by":"crossref","unstructured":"Fakhari A, Subramony JA. Engineered in-situ depot-forming hydrogels for intratumoral drug delivery. J Control Release. 2015;220(Pt A):465-475.","DOI":"10.1016\/j.jconrel.2015.11.014"},{"key":"1349_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jconrel.2014.05.057","volume":"190","author":"SP Schwendeman","year":"2014","unstructured":"Schwendeman SP, et al. Injectable controlled release depots for large molecules. J Control Release. 2014;190:240\u201353.","journal-title":"J Control Release"},{"key":"1349_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2020.110988","volume":"113","author":"K Wang","year":"2020","unstructured":"Wang K, et al. Comparative study of electrospun crystal-based and composite-based drug nano depots. Mater Sci Eng C Mater Biol Appl. 2020;113.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1349_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119707","volume":"587","author":"P Zhang","year":"2020","unstructured":"Zhang P, et al. Comparison of three in-situ gels composed of different oil types. Int J Pharm. 2020;587.","journal-title":"Int J Pharm"},{"issue":"3","key":"1349_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1590\/s1677-5538.ibju.2019.0212","volume":"46","author":"CSM de Freitas","year":"2020","unstructured":"de Freitas CSM, Soares AN. Efficacy of Leuprorelide acetate (Eligard(R)) in daily practice in Brazil: a retrospective study with depot formulations in patients with prostate cancer. Int Braz J Urol. 2020;46(3):383\u20139.","journal-title":"Int Braz J Urol"},{"issue":"10","key":"1349_CR17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.addr.2009.04.010","volume":"61","author":"NL Elstad","year":"2009","unstructured":"Elstad NL, Fowers KD. OncoGel (ReGel\/paclitaxel)\u2013clinical applications for a novel paclitaxel delivery system. Adv Drug Deliv Rev. 2009;61(10):785\u201394.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2 Suppl 1","key":"1349_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0090-4295(02)02396-8","volume":"61","author":"O Sartor","year":"2003","unstructured":"Sartor O. Eligard: leuprolide acetate in a novel sustained-release delivery system. Urology. 2003;61(2 Suppl 1):25\u201331.","journal-title":"Urology"},{"key":"1349_CR19","doi-asserted-by":"crossref","unstructured":"Srikhao N, et al. Multi-Responsive Optimization of Novel pH-Sensitive Hydrogel Beads Based on Basil Seed Mucilage, Alginate, and Magnetic Particles. Gels. 2022;8(5).","DOI":"10.3390\/gels8050274"},{"key":"1349_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2022.120349","volume":"302","author":"R Su","year":"2023","unstructured":"Su R, et al. Polydopamine\/tannic acid\/chitosan\/poloxamer 407\/188 thermosensitive hydrogel for antibacterial and wound healing. Carbohydr Polym. 2023;302.","journal-title":"Carbohydr Polym"},{"key":"1349_CR21","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ijbiomac.2022.06.210","volume":"216","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, et al. A poloxamer\/hyaluronic acid\/chitosan-based thermosensitive hydrogel that releases dihydromyricetin to promote wound healing. Int J Biol Macromol. 2022;216:475\u201386.","journal-title":"Int J Biol Macromol"},{"issue":"10","key":"1349_CR22","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1002\/jps.23250","volume":"101","author":"TA Ahmed","year":"2012","unstructured":"Ahmed TA, et al. Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol. J Pharm Sci. 2012;101(10):3753\u201362.","journal-title":"J Pharm Sci"},{"issue":"1","key":"1349_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jconrel.2013.08.024","volume":"172","author":"M Parent","year":"2013","unstructured":"Parent M, et al. PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release. J Control Release. 2013;172(1):292\u2013304.","journal-title":"J Control Release"},{"key":"1349_CR24","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.msec.2018.11.058","volume":"96","author":"H Kamali","year":"2019","unstructured":"Kamali H, et al. In-vitro, ex-vivo, and in-vivo evaluation of buprenorphine HCl release from an in situ forming gel of PLGA-PEG-PLGA using Nmethyl2pyrrolidone as solvent. Mater Sci Eng C Mater Biol Appl. 2019;96:561\u201375.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"1349_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121183","volume":"609","author":"Z Li","year":"2021","unstructured":"Li Z, et al. An in vitro gel-based system for characterizing and predicting the long-term performance of PLGA in situ forming implants. Int J Pharm. 2021;609.","journal-title":"Int J Pharm"},{"key":"1349_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2021.112246","volume":"221","author":"S Biswas","year":"2021","unstructured":"Biswas S, et al. Enhanced permeability and photoprotective potential of optimized p-coumaric acid-phospholipid complex loaded gel against UVA mediated oxidative stress. J Photochem Photobiol B. 2021;221.","journal-title":"J Photochem Photobiol B"},{"key":"1349_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.173951","volume":"897","author":"X Xu","year":"2021","unstructured":"Xu X, et al. Fabrication of oral nanovesicle in-situ gel based on Epigallocatechin gallate phospholipid complex: Application in dental anti-caries. Eur J Pharmacol. 2021;897.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1349_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ijpharm.2005.12.050","volume":"314","author":"C Guse","year":"2006","unstructured":"Guse C, et al. Biocompatibility and erosion behavior of implants made of triglycerides and blends with cholesterol and phospholipids. Int J Pharm. 2006;314(2):153\u201360.","journal-title":"Int J Pharm"},{"issue":"3","key":"1349_CR29","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.xphs.2015.12.002","volume":"105","author":"N Xiang","year":"2016","unstructured":"Xiang N, et al. An Injectable Gel Platform for the Prolonged Therapeutic Effect of Pitavastatin in the Management of Hyperlipidemia. J Pharm Sci. 2016;105(3):1148\u201355.","journal-title":"J Pharm Sci"},{"issue":"6","key":"1349_CR30","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","volume":"26","author":"A Puri","year":"2009","unstructured":"Puri A, et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst. 2009;26(6):523\u201380.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"11","key":"1349_CR31","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1111\/j.2042-7158.2010.01024.x","volume":"62","author":"H Bunjes","year":"2010","unstructured":"Bunjes H. Lipid nanoparticles for the delivery of poorly water-soluble drugs. J Pharm Pharmacol. 2010;62(11):1637\u201345.","journal-title":"J Pharm Pharmacol"},{"key":"1349_CR32","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.colsurfb.2019.01.003","volume":"176","author":"T Zhang","year":"2019","unstructured":"Zhang T, et al. Injectable and biodegradable phospholipid-based phase separation gel for sustained delivery of insulin. Colloids Surf B Biointerfaces. 2019;176:194\u2013201.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"1\u20132","key":"1349_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ijpharm.2014.05.036","volume":"471","author":"LR Du","year":"2014","unstructured":"Du LR, et al. Development and evaluation of liquid embolic agents based on liquid crystalline material of glyceryl monooleate. Int J Pharm. 2014;471(1\u20132):285\u201396.","journal-title":"Int J Pharm"},{"issue":"11","key":"1349_CR34","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1517\/17425247.2013.824874","volume":"10","author":"T Ren","year":"2013","unstructured":"Ren T, et al. Lipid emulsions in parenteral nutrition: current applications and future developments. Expert Opin Drug Deliv. 2013;10(11):1533\u201349.","journal-title":"Expert Opin Drug Deliv"},{"key":"1349_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.biomaterials.2016.08.007","volume":"105","author":"L Han","year":"2016","unstructured":"Han L, et al. An injectable, low-toxicity phospholipid-based phase separation gel that induces strong and persistent immune responses in mice. Biomaterials. 2016;105:185\u201394.","journal-title":"Biomaterials"},{"key":"1349_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.actbio.2017.06.013","volume":"58","author":"H Li","year":"2017","unstructured":"Li H, et al. An in situ-forming phospholipid-based phase transition gel prolongs the duration of local anesthesia for ropivacaine with minimal toxicity. Acta Biomater. 2017;58:136\u201345.","journal-title":"Acta Biomater"},{"key":"1349_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.carbpol.2019.03.001","volume":"214","author":"J Luo","year":"2019","unstructured":"Luo J, et al. Efficient weapon for protracted warfare to malaria: A chondroitin sulfate derivates-containing injectable, ultra-long-lasting meshy-gel system. Carbohydr Polym. 2019;214:131\u201341.","journal-title":"Carbohydr Polym"},{"issue":"12","key":"1349_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201900046","volume":"15","author":"Y Liang","year":"2019","unstructured":"Liang Y, et al. Adhesive Hemostatic Conducting Injectable Composite Hydrogels with Sustained Drug Release and Photothermal Antibacterial Activity to Promote Full-Thickness Skin Regeneration During Wound Healing. Small. 2019;15(12).","journal-title":"Small"},{"issue":"6","key":"1349_CR39","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/mp500070m","volume":"11","author":"JF Remenar","year":"2014","unstructured":"Remenar JF. Making the leap from daily oral dosing to long-acting injectables: lessons from the antipsychotics. Mol Pharm. 2014;11(6):1739\u201349.","journal-title":"Mol Pharm"},{"issue":"12","key":"1349_CR40","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3109\/03639045.2010.488694","volume":"36","author":"K Wang","year":"2010","unstructured":"Wang K, et al. Self-assembled L-alanine derivative organogel as in situ drug delivery implant: characterization, biodegradability, and biocompatibility. Drug Dev Ind Pharm. 2010;36(12):1511\u201321.","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"1349_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/1872211309666150311095424","volume":"9","author":"SK Yadav","year":"2015","unstructured":"Yadav SK, Khan G, Mishra B. Advances in patents related to intrapocket technology for the management of periodontitis. Recent Pat Drug Deliv Formul. 2015;9(2):129\u201345.","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"1349_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2014.12.042","volume":"45","author":"T Zhang","year":"2015","unstructured":"Zhang T, et al. A high-efficiency, low-toxicity, phospholipids-based phase separation gel for long-term delivery of peptides. Biomaterials. 2015;45:1\u20139.","journal-title":"Biomaterials"},{"issue":"10","key":"1349_CR43","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1021\/mp500019p","volume":"11","author":"W Wu","year":"2014","unstructured":"Wu W, et al. A novel doxorubicin-loaded in situ forming gel based high concentration of phospholipid for intratumoral drug delivery. Mol Pharm. 2014;11(10):3378\u201385.","journal-title":"Mol Pharm"},{"issue":"1\u20132","key":"1349_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ijpharm.2010.05.042","volume":"395","author":"JJ Xuan","year":"2010","unstructured":"Xuan JJ, et al. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam. Int J Pharm. 2010;395(1\u20132):317\u201323.","journal-title":"Int J Pharm"},{"issue":"4","key":"1349_CR45","first-page":"303","volume":"61","author":"H Chen","year":"2007","unstructured":"Chen H, et al. Characterization of pH- and temperature-sensitive hydrogel nanoparticles for controlled drug release. PDA J Pharm Sci Technol. 2007;61(4):303\u201313.","journal-title":"PDA J Pharm Sci Technol"},{"key":"1349_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jconrel.2013.12.020","volume":"176","author":"RR Thakur","year":"2014","unstructured":"Thakur RR, McMillan HL, Jones DS. Solvent induced phase inversion-based in situ forming controlled release drug delivery implants. J Control Release. 2014;176:8\u201323.","journal-title":"J Control Release"},{"key":"1349_CR47","doi-asserted-by":"crossref","unstructured":"HPS AK, et al. A review on chitosan-cellulose blends and nanocellulose reinforced chitosan biocomposites: Properties and their applications. Carbohydr Polym. 2016;150:216-26.","DOI":"10.1016\/j.carbpol.2016.05.028"},{"issue":"4","key":"1349_CR48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/01616412.2017.1281197","volume":"39","author":"Q Ning","year":"2017","unstructured":"Ning Q, et al. Neurodegenerative changes and neuroapoptosis induced by systemic lipopolysaccharide administration are reversed by dexmedetomidine treatment in mice. Neurol Res. 2017;39(4):357\u201366.","journal-title":"Neurol Res"},{"issue":"2","key":"1349_CR49","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ijpharm.2014.11.072","volume":"478","author":"S Milak","year":"2015","unstructured":"Milak S, Zimmer A. Glycerol monooleate liquid crystalline phases used in drug delivery systems. Int J Pharm. 2015;478(2):569\u201387.","journal-title":"Int J Pharm"},{"issue":"2","key":"1349_CR50","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jconrel.2012.04.016","volume":"161","author":"S Kempe","year":"2012","unstructured":"Kempe S, Mader K. In situ forming implants - an attractive formulation principle for parenteral depot formulations. J Control Release. 2012;161(2):668\u201379.","journal-title":"J Control Release"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-023-01349-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-023-01349-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-023-01349-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T09:15:12Z","timestamp":1696238112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-023-01349-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1349"],"URL":"https:\/\/doi.org\/10.1007\/s13346-023-01349-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2363215\/v1","asserted-by":"object"}]},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"6 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of Chongqing Management Approach of Laboratory Animal (chongqing government order NO.195).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}